HEADER MACROGLOBULIN 07-NOV-97 1AYO TITLE RECEPTOR BINDING DOMAIN OF BOVINE ALPHA-2-MACROGLOBULIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-2-MACROGLOBULIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RECEPTOR-BINDING DOMAIN; COMPND 5 OTHER_DETAILS: N-LINKED GLYCOSYLATION SITE ON ASN B 68 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 TISSUE: PLASMA KEYWDS MACROGLOBULIN, RECEPTOR BINDING DOMAIN EXPDTA X-RAY DIFFRACTION AUTHOR L.B.JENNER,L.HUSTED,S.THIRUP,L.SOTTRUP-JENSEN,J.NYBORG REVDAT 6 13-NOV-24 1AYO 1 HETSYN REVDAT 5 29-JUL-20 1AYO 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 13-JUL-11 1AYO 1 VERSN REVDAT 3 24-FEB-09 1AYO 1 VERSN REVDAT 2 13-JAN-99 1AYO 3 HET SOURCE COMPND REMARK REVDAT 2 2 3 HETATM JRNL KEYWDS HEADER REVDAT 2 3 3 MODRES LINK REVDAT 1 25-NOV-98 1AYO 0 JRNL AUTH L.JENNER,L.HUSTED,S.THIRUP,L.SOTTRUP-JENSEN,J.NYBORG JRNL TITL CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF ALPHA JRNL TITL 2 2-MACROGLOBULIN. JRNL REF STRUCTURE V. 6 595 1998 JRNL REFN ISSN 0969-2126 JRNL PMID 9634697 JRNL DOI 10.1016/S0969-2126(98)00061-6 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : THIN SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.197 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.195 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1032 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 35876 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.183 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.180 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 2.500 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 903 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 30705 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2037 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 304 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2370.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 9496 REMARK 3 NUMBER OF RESTRAINTS : 8488 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 ANGLE DISTANCES (A) : 0.020 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.034 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.029 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.040 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.007 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.092 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL. (1973) 91: 201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NAG REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC SCALING APPLIED BY THE REMARK 3 METHOD OF PARKIN, MOEZZI & HOPE, J.APPL.CRYST. 28 (1995)53-56. REMARK 4 REMARK 4 1AYO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171417. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : MAR-97 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : DUEL SLITS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35602 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 33.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : 0.07300 REMARK 200 FOR THE DATA SET : 23.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.26500 REMARK 200 R SYM FOR SHELL (I) : 0.26500 REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: SHELXL-97 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: DATA WERE COLLECTED AT THE X-RAY DIFFRACTION BEAMLINE IN REMARK 200 TRIESTE, ITALY. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 38% PEGMMES 2000, 25 MM CACL2, 100 MM REMARK 280 HEPES, PH 6.9 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 24.07633 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 48.15267 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 48.15267 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 24.07633 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 42 -165.70 -64.27 REMARK 500 ARG A 66 98.23 -179.46 REMARK 500 SER A 67 -134.41 160.75 REMARK 500 THR A 87 -166.97 -120.93 REMARK 500 ASP A 105 87.89 58.87 REMARK 500 SER B 67 -151.41 -85.06 REMARK 500 ASN B 68 36.25 -89.17 REMARK 500 THR B 87 -166.62 -115.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 133 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 76 OD1 REMARK 620 2 HOH A 134 O 69.3 REMARK 620 3 ASP B 120 O 150.3 140.4 REMARK 620 4 GLU B 121 OE2 87.9 92.7 90.6 REMARK 620 5 HOH B 134 O 75.8 144.9 74.5 89.9 REMARK 620 6 HOH B 148 O 89.0 92.4 88.8 172.8 83.0 REMARK 620 7 HOH B 201 O 142.3 73.2 67.2 98.2 140.9 88.2 REMARK 620 N 1 2 3 4 5 6 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: S1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: N-LINKED GLYCOSYLATION SITE REMARK 800 REMARK 800 SITE_IDENTIFIER: S2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: N-LINKED GLYCOSYLATION SITE DBREF 1AYO A 3 132 UNP P01023 A2MG_HUMAN 1338 1468 DBREF 1AYO B 3 132 UNP P01023 A2MG_HUMAN 1338 1468 SEQADV 1AYO GLU A 9 UNP P01023 GLY 1344 CONFLICT SEQADV 1AYO GLY A 19 UNP P01023 GLU 1354 CONFLICT SEQADV 1AYO ILE A 35 UNP P01023 THR 1370 CONFLICT SEQADV 1AYO PRO A 39 UNP P01023 SER 1374 CONFLICT SEQADV 1AYO A UNP P01023 HIS 1404 DELETION SEQADV 1AYO ASN A 76 UNP P01023 SER 1412 CONFLICT SEQADV 1AYO THR A 87 UNP P01023 SER 1423 CONFLICT SEQADV 1AYO GLU A 89 UNP P01023 GLN 1425 CONFLICT SEQADV 1AYO THR A 92 UNP P01023 SER 1428 CONFLICT SEQADV 1AYO THR A 94 UNP P01023 PHE 1430 CONFLICT SEQADV 1AYO ILE A 101 UNP P01023 VAL 1437 CONFLICT SEQADV 1AYO VAL A 124 UNP P01023 ILE 1460 CONFLICT SEQADV 1AYO SER A 128 UNP P01023 ASN 1464 CONFLICT SEQADV 1AYO GLU B 9 UNP P01023 GLY 1344 CONFLICT SEQADV 1AYO GLY B 19 UNP P01023 GLU 1354 CONFLICT SEQADV 1AYO ILE B 35 UNP P01023 THR 1370 CONFLICT SEQADV 1AYO PRO B 39 UNP P01023 SER 1374 CONFLICT SEQADV 1AYO B UNP P01023 HIS 1404 DELETION SEQADV 1AYO ASN B 76 UNP P01023 SER 1412 CONFLICT SEQADV 1AYO THR B 87 UNP P01023 SER 1423 CONFLICT SEQADV 1AYO GLU B 89 UNP P01023 GLN 1425 CONFLICT SEQADV 1AYO THR B 92 UNP P01023 SER 1428 CONFLICT SEQADV 1AYO THR B 94 UNP P01023 PHE 1430 CONFLICT SEQADV 1AYO ILE B 101 UNP P01023 VAL 1437 CONFLICT SEQADV 1AYO VAL B 124 UNP P01023 ILE 1460 CONFLICT SEQADV 1AYO SER B 128 UNP P01023 ASN 1464 CONFLICT SEQRES 1 A 130 GLU PHE PRO PHE ALA LEU GLU VAL GLN THR LEU PRO GLN SEQRES 2 A 130 THR CYS ASP GLY PRO LYS ALA HIS THR SER PHE GLN ILE SEQRES 3 A 130 SER LEU SER VAL SER TYR ILE GLY SER ARG PRO ALA SER SEQRES 4 A 130 ASN MET ALA ILE VAL ASP VAL LYS MET VAL SER GLY PHE SEQRES 5 A 130 ILE PRO LEU LYS PRO THR VAL LYS MET LEU GLU ARG SER SEQRES 6 A 130 ASN VAL SER ARG THR GLU VAL SER ASN ASN HIS VAL LEU SEQRES 7 A 130 ILE TYR LEU ASP LYS VAL THR ASN GLU THR LEU THR LEU SEQRES 8 A 130 THR PHE THR VAL LEU GLN ASP ILE PRO VAL ARG ASP LEU SEQRES 9 A 130 LYS PRO ALA ILE VAL LYS VAL TYR ASP TYR TYR GLU THR SEQRES 10 A 130 ASP GLU PHE ALA VAL ALA GLU TYR SER ALA PRO CYS SER SEQRES 1 B 130 GLU PHE PRO PHE ALA LEU GLU VAL GLN THR LEU PRO GLN SEQRES 2 B 130 THR CYS ASP GLY PRO LYS ALA HIS THR SER PHE GLN ILE SEQRES 3 B 130 SER LEU SER VAL SER TYR ILE GLY SER ARG PRO ALA SER SEQRES 4 B 130 ASN MET ALA ILE VAL ASP VAL LYS MET VAL SER GLY PHE SEQRES 5 B 130 ILE PRO LEU LYS PRO THR VAL LYS MET LEU GLU ARG SER SEQRES 6 B 130 ASN VAL SER ARG THR GLU VAL SER ASN ASN HIS VAL LEU SEQRES 7 B 130 ILE TYR LEU ASP LYS VAL THR ASN GLU THR LEU THR LEU SEQRES 8 B 130 THR PHE THR VAL LEU GLN ASP ILE PRO VAL ARG ASP LEU SEQRES 9 B 130 LYS PRO ALA ILE VAL LYS VAL TYR ASP TYR TYR GLU THR SEQRES 10 B 130 ASP GLU PHE ALA VAL ALA GLU TYR SER ALA PRO CYS SER MODRES 1AYO ASN B 68 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET CA B 133 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CA CALCIUM ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 4 CA CA 2+ FORMUL 5 HOH *304(H2 O) HELIX 1 1 PRO A 20 HIS A 23 5 4 HELIX 2 2 LYS A 58 LEU A 64 1 7 HELIX 3 3 PRO B 20 HIS B 23 5 4 HELIX 4 4 LYS B 58 ARG B 66 1 9 SHEET 1 A 4 PHE A 6 LEU A 13 0 SHEET 2 A 4 SER A 25 TYR A 34 -1 N SER A 33 O ALA A 7 SHEET 3 A 4 LEU A 91 GLN A 99 -1 N VAL A 97 O PHE A 26 SHEET 4 A 4 PHE A 54 PRO A 56 -1 N ILE A 55 O LEU A 98 SHEET 1 B 5 PHE A 122 TYR A 127 0 SHEET 2 B 5 ALA A 109 ASP A 115 -1 N VAL A 113 O ALA A 123 SHEET 3 B 5 ALA A 44 LYS A 49 -1 N ASP A 47 O LYS A 112 SHEET 4 B 5 HIS A 78 LEU A 83 -1 N LEU A 83 O ALA A 44 SHEET 5 B 5 VAL A 69 SER A 75 -1 N SER A 75 O HIS A 78 SHEET 1 C 4 PHE B 6 LEU B 13 0 SHEET 2 C 4 SER B 25 TYR B 34 -1 N SER B 33 O ALA B 7 SHEET 3 C 4 LEU B 91 GLN B 99 -1 N VAL B 97 O PHE B 26 SHEET 4 C 4 PHE B 54 PRO B 56 -1 N ILE B 55 O LEU B 98 SHEET 1 D 5 PHE B 122 TYR B 127 0 SHEET 2 D 5 ALA B 109 ASP B 115 -1 N VAL B 113 O ALA B 123 SHEET 3 D 5 ALA B 44 LYS B 49 -1 N ASP B 47 O LYS B 112 SHEET 4 D 5 HIS B 78 LEU B 83 -1 N LEU B 83 O ALA B 44 SHEET 5 D 5 VAL B 69 SER B 75 -1 N SER B 75 O HIS B 78 SSBOND 1 CYS A 17 CYS A 131 1555 1555 2.05 SSBOND 2 CYS B 17 CYS B 131 1555 1555 2.04 LINK ND2 ASN B 68 C1 NAG C 1 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK OD1 ASN A 76 CA CA B 133 2665 1555 2.34 LINK O HOH A 134 CA CA B 133 2665 1555 2.38 LINK O ASP B 120 CA CA B 133 1555 1555 2.37 LINK OE2 GLU B 121 CA CA B 133 1555 1555 2.34 LINK CA CA B 133 O HOH B 134 1555 1555 2.30 LINK CA CA B 133 O HOH B 148 1555 1555 2.44 LINK CA CA B 133 O HOH B 201 1555 1555 2.35 CISPEP 1 LEU A 13 PRO A 14 0 5.80 CISPEP 2 LEU B 13 PRO B 14 0 1.52 SITE 1 S1 2 ASN A 68 ASN A 88 SITE 1 S2 2 ASN B 68 ASN B 88 CRYST1 107.570 107.570 72.229 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009296 0.005367 0.000000 0.00000 SCALE2 0.000000 0.010734 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013845 0.00000